Experimental effect of Nup88-shRNA on growth and invasiveness of human colon cancer cell line HT-29
Nan LI,Zhan-sheng HU,Bao-quan WANG,Hong-zhi SUN,Zhi-tu ZHU,Yu-qiang LI,Chen LI,Yu WANG
DOI: https://doi.org/10.13339/j.cnki.sglc.20160712.018
2016-01-01
Abstract:Objective To construct recombinant lentivirus-mediated vector for Nup88-shRNA and study its impact on prolif-eration, adhesion, invasion and metastasis of HT-29, and find new gene therapy targets for colon cancer. Methods The po-tency test was performed after construction and package of the recombinant lentivirus-mediated vector for Nup88, and HT-29 cells were transfected with the best multiple infection index. The test was divided into 3 groups, silence group, negative control group and blank group, and the silence group were further divided into 4 sub-group, Nup88-shRNA1, Nup88-shRNA2, Nup88-shRNA3 and Nup88-shRNA4. The efficiency of each group was evaluated by detecting mRNA and protein expression in HT-29 cells by reverse transcription-polymerase chain reaction(RT-PCR) and Western blot. MTT method and flow cytome-try were performed to test the impact on proliferation and apoptosis of HT-29 cells after Nup88 silencing. Cell invasion assay was performed to evaluate the invasiveness of HT-29 after Nup88 silencing. Results Four silence sub-group and negative con-trol group were successfully constructed, and the titer was 4E+8 TU/mL for all of them. Compared with negative control group and blank group, the expression of Nup88 mRNA of silence group were significantly different (P<0.01). After transfection with Nup88 shRNA1, the silencing rate reached to 86%. The degree of cell proliferation was significantly decreased in silence group, and as compared with negative control group and blank group, there were significant differences(P< 0.05). The apoptotic rate in silence group(30.28% ± 0.19%) was increased, and when compared with negative control group(4.15% ± 0.24%) and blank group(2.98%± 0.27%), there were significant differences(P<0.05). After 24-hour of tumor cell culture, trans-membrane cell (120.5 ± 8.7) was decreased and inhibition rate(49.22 %) was increased in silence group, and when compared with negative <br> control group(232.2 ± 13.4,-2.14%) and blank group(276.4 ± 10.2, 0), there were significant differences(P<0.05). Conclusion It is demonstrated that Nup88 recombinant lentivirus could successfully down regulate Nup88 gene expression in HT-29 via RNAi, and significantly inhibit proliferation and distant invasiveness of the tumor cells.